Reverse cardiac remodeling by SGLT2i in non-diabetic patients with HFrEF

10' education - Feb. 22, 2021 - Carlos Santos-Gallego, MD - New York, NY, USA

Video navigation menu

Design of the EMPA-TROPISM trial 5:36
Results of the trial 8:46

Educational information

This video was recorded in response to a recent publication in J Am Col Cardiol by Carlos Santos-Gallego and colleagues.

Faculty

Carlos Santos-Gallego is a cardiologist at Icahn School of Medicine at Mount Sinai, New York, NY, USA

Disclosures

This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of this study

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.